[시장보고서]세계의 심장 판막 기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

세계의 심장 판막 기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Heart Valve Devices Market (Type of Heart Valve: Aortic Valve, Mitral Valve, Tricuspid Valve, and Pulmonary Valve; and Material: Biological Valves, and Mechanical Valves) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1552706

리서치사 : Transparency Market Research

발행일 : 2024년 07월

페이지 정보 : 영문 252 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,431,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,795,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,160,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

심장 판막 기기 시장 - 조사 범위

TMR의 조사 보고서 '심장 판막 기기 세계 시장'은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사했습니다. 본 보고서는 2024년을 기준년, 2034년을 예측년으로 하여 2018년부터 2034년까지 세계 심장 판막 기기 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 심장 판막 기기 시장의 복합 연간 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 심장 판막 기기 시장을 추찰했습니다.

시장 현황
2023년 시장 규모	109억 달러
2034년 시장 규모	382억 달러
CAGR	11.7%

이 보고서는 세계 심장 판막 기기 시장 경쟁 구도를 조사했습니다. 세계 심장 판막 기기 시장에서 사업을 전개하는 주요 기업이 확인되고 각 기업은 다양한 속성으로 프로파일 링됩니다. 기업 개요, 재무 상황, 최근 동향, SWOT 등이 본 보고서에서 소개되고 있는 세계의 심장 판막 기기 시장에서의 기업의 속성입니다.

심혈관 질환의 세계적 부담에 관한 고찰
주요 지역/국가의 규제 상황
심장혈관 수술의 개요
주요 산업 이벤트(제품 승인, 파트너십, 협업)
심장 판막 수술 분야의 기술적 진보
주요 지역/국가의 상환 시나리오
가격 동향
PEST 분석
주요 제품/브랜드 분석
심혈관 질환의 세계적 부담에 관한 고찰

제6장 세계 시장 분석과 예측 : 심장 판막유형별

소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 심장 판막유형별, 2020-2034년
- 대동맥판
  - 20mm 미만
  - 20-23mm
  - 23-26mm
  - 26mm 이상
- 승모판
  - 26mm 미만
  - 26-28mm
  - 29-31mm
  - 31mm 이상
- 삼첨판
- 폐동맥판
심장 판막유형별 시장의 매력

제7장 세계 시장 분석과 예측 : 재료별

소개 및 정의
주요 조사 결과/진전
시장 매출 예측 :재료별, 2020-2034년
- 생체 밸브
  - TAVI
  - 수술
  - 기타
- 기계 밸브
재료별 시장의 매력

제8장 세계 시장 분석과 예측 : 연령층별

소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 연령층별, 2020-2034년
- 소아
- 성인
- 고령자
연령층별 시장의 매력

제9장 세계 시장 분석과 예측 : 최종 사용자별

소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 최종 사용자별, 2020-2034년
- 병원
- 외래수술센터(ASC)
- 기타
최종 사용자별 시장의 매력

제10장 세계 시장 분석과 예측 : 지역별

주요 조사 결과
시장 매출 예측 :지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
지역별 시장의 매력

제11장 북미 시장 분석과 예측

미국
캐나다

제12장 유럽 시장 분석과 예측

독일
영국
프랑스
스페인
이탈리아
기타 유럽

제13장 아시아태평양 시장 분석과 예측

중국
일본
인도
호주 및 뉴질랜드
기타 아시아태평양

제14장 라틴아메리카 시장 분석과 예측

브라질
멕시코
기타 라틴아메리카

제15장 중동 및 아프리카 시장 분석과 예측

GCC 국가
남아프리카
기타 중동 및 아프리카

제16장 경쟁 구도

시장기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
기업 프로파일
- Medtronic plc
- Boston Scientific Corporation
- Abbott
- Edwards Lifesciences Corporation
- Foldax Inc.
- Novostia SA
- Meril Life Sciences Pvt. Ltd.
- Corcym UK Limited
- JenaValve Technology, Inc.
- Micro Interventional Devices, Inc.
- Auto Tissue Berlin GmbH
- Anteris Technologies Ltd
- Thubrikar Aortic Valve, Inc.
- MicroPort Scientific Corporation
- Biosensors International Group, Ltd.

JHS

영문 목차

영문목차

Heart Valve Devices Market - Scope of Report

TMR's report on the global heart valve devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global heart valve devices market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global heart valve devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the heart valve devices market.

Market Snapshot
Market Value in 2023	US$ 10.9 Bn
Market Value in 2034	US$ 38.2 Bn
CAGR	11.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global heart valve devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global heart valve devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global heart valve devices market.

The report delves into the competitive landscape of the global heart valve devices market. Key players operating in the global heart valve devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global heart valve devices market profiled in this report.

Key Questions Answered in Global heart valve devices Market Report:

What is the sales/revenue generated by heart valve devices across all regions during the forecast period?
What are the opportunities in the global heart valve devices market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Heart Valve Devices Market - Research Objectives and Research Approach

The comprehensive report on the global heart valve devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global heart valve devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global heart valve devices market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heart Valve Devices Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Heart Valve Devices Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Insights on Global Burden of Cardiovascular Diseases
5.2. Regulatory Landscape for Heart Valve Devices in Key Regions / Countries
5.3. Overview on Cardiovascular Surgical Procedures
5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
5.5. Technological Advancements in the Field of Heart Valve Surgeries
5.6. Reimbursement Scenario across Key Regions / Countries
5.7. Pricing Trends of Heart Valve Devices
5.8. PEST Analysis
5.9. Key Product / Brand Analysis
5.10. Insights on Global Burden of Cardiovascular Diseases

6. Global Heart Valve Devices Market Analysis and Forecasts, By Type of Heart Valve

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type of Heart Valve, 2020-2034
- 6.3.1. Aortic Valve
  - 6.3.1.1. Less than 20 mm
  - 6.3.1.2. 20-23 mm
  - 6.3.1.3. 23-26 mm
  - 6.3.1.4. More than 26 mm
- 6.3.2. Mitral Valve
  - 6.3.2.1. Less than 26 mm
  - 6.3.2.2. 26-28 mm
  - 6.3.2.3. 29-31 mm
  - 6.3.2.4. More than 31 mm
- 6.3.3. Tricuspid Valve
- 6.3.4. Pulmonary Valve
6.4. Market Attractiveness By Type of Heart Valve

7. Global Heart Valve Devices Market Analysis and Forecasts, By Material

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Material, 2020-2034
- 7.3.1. Biological Valves
  - 7.3.1.1. TAVI
  - 7.3.1.2. Surgical
  - 7.3.1.3. Others
- 7.3.2. Mechanical Valves
7.4. Market Attractiveness By Material

8. Global Heart Valve Devices Market Analysis and Forecasts, By Age Group

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Age Group, 2020-2034
- 8.3.1. Pediatric Patients
- 8.3.2. Adults
- 8.3.3. Geriatric Patients
8.4. Market Attractiveness By Age Group

9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Others
9.4. Market Attractiveness By End-user

10. Global Heart Valve Devices Market Analysis and Forecasts, By Region

10.1. Key Findings
10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region

11. North America Heart Valve Devices Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 11.2.1. Aortic Valve
  - 11.2.1.1. Less than 20 mm
  - 11.2.1.2. 20-23 mm
  - 11.2.1.3. 23-26 mm
  - 11.2.1.4. More than 26 mm
- 11.2.2. Mitral Valve
  - 11.2.2.1. Less than 26 mm
  - 11.2.2.2. 26-28 mm
  - 11.2.2.3. 29-31 mm
  - 11.2.2.4. More than 31 mm
- 11.2.3. Tricuspid Valve
- 11.2.4. Pulmonary Valve
11.3. Market Value Forecast By Material, 2020-2034
- 11.3.1. Biological Valves
  - 11.3.1.1. TAVI
  - 11.3.1.2. Surgical
  - 11.3.1.3. Others
- 11.3.2. Mechanical Valves
11.4. Market Value Forecast By Age Group, 2020-2034
- 11.4.1. Pediatric Patients
- 11.4.2. Adults
- 11.4.3. Geriatric Patients
11.5. Market Value Forecast By End-user, 2020-2034
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Others
11.6. Market Value Forecast By Country, 2020-2034
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Type of Heart Valve
- 11.7.2. By Material
- 11.7.3. By Age Group
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Heart Valve Devices Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 12.2.1. Aortic Valve
  - 12.2.1.1. Less than 20 mm
  - 12.2.1.2. 20-23 mm
  - 12.2.1.3. 23-26 mm
  - 12.2.1.4. More than 26 mm
- 12.2.2. Mitral Valve
  - 12.2.2.1. Less than 26 mm
  - 12.2.2.2. 26-28 mm
  - 12.2.2.3. 29-31 mm
  - 12.2.2.4. More than 31 mm
- 12.2.3. Tricuspid Valve
- 12.2.4. Pulmonary Valve
12.3. Market Value Forecast By Material, 2020-2034
- 12.3.1. Biological Valves
  - 12.3.1.1. TAVI
  - 12.3.1.2. Surgical
  - 12.3.1.3. Others
- 12.3.2. Mechanical Valves
12.4. Market Value Forecast By Age Group, 2020-2034
- 12.4.1. Pediatric Patients
- 12.4.2. Adults
- 12.4.3. Geriatric Patients
12.5. Market Value Forecast By End-user, 2020-2034
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Others
12.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Type of Heart Valve
- 12.7.2. By Material
- 12.7.3. By Age Group
- 12.7.4. By End-user
- 12.7.5. By Country / Sub-region

13. Asia Pacific Heart Valve Devices Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 13.2.1. Aortic Valve
  - 13.2.1.1. Less than 20 mm
  - 13.2.1.2. 20-23 mm
  - 13.2.1.3. 23-26 mm
  - 13.2.1.4. More than 26 mm
- 13.2.2. Mitral Valve
  - 13.2.2.1. Less than 26 mm
  - 13.2.2.2. 26-28 mm
  - 13.2.2.3. 29-31 mm
  - 13.2.2.4. More than 31 mm
- 13.2.3. Tricuspid Valve
- 13.2.4. Pulmonary Valve
13.3. Market Value Forecast By Material, 2020-2034
- 13.3.1. Biological Valves
  - 13.3.1.1. TAVI
  - 13.3.1.2. Surgical
  - 13.3.1.3. Others
- 13.3.2. Mechanical Valves
13.4. Market Value Forecast By Age Group, 2020-2034
- 13.4.1. Pediatric Patients
- 13.4.2. Adults
- 13.4.3. Geriatric Patients
13.5. Market Value Forecast By End-user, 2020-2034
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Others
13.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Type of Heart Valve
- 13.7.2. By Material
- 13.7.3. By Age Group
- 13.7.4. By End-user
- 13.7.5. By Country / Sub-region

14. Latin America Heart Valve Devices Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 14.2.1. Aortic Valve
  - 14.2.1.1. Less than 20 mm
  - 14.2.1.2. 20-23 mm
  - 14.2.1.3. 23-26 mm
  - 14.2.1.4. More than 26 mm
- 14.2.2. Mitral Valve
  - 14.2.2.1. Less than 26 mm
  - 14.2.2.2. 26-28 mm
  - 14.2.2.3. 29-31 mm
  - 14.2.2.4. More than 31 mm
- 14.2.3. Tricuspid Valve
- 14.2.4. Pulmonary Valve
14.3. Market Value Forecast By Material, 2020-2034
- 14.3.1. Biological Valves
  - 14.3.1.1. TAVI
  - 14.3.1.2. Surgical
  - 14.3.1.3. Others
- 14.3.2. Mechanical Valves
14.4. Market Value Forecast By Age Group, 2020-2034
- 14.4.1. Pediatric Patients
- 14.4.2. Adults
- 14.4.3. Geriatric Patients
14.5. Market Value Forecast By End-user, 2020-2034
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Others
14.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Type of Heart Valve
- 14.7.2. By Material
- 14.7.3. By Age Group
- 14.7.4. By End-user
- 14.7.5. By Country / Sub-region

15. Middle East & Africa Heart Valve Devices Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 15.2.1. Aortic Valve
  - 15.2.1.1. Less than 20 mm
  - 15.2.1.2. 20-23 mm
  - 15.2.1.3. 23-26 mm
  - 15.2.1.4. More than 26 mm
- 15.2.2. Mitral Valve
  - 15.2.2.1. Less than 26 mm
  - 15.2.2.2. 26-28 mm
  - 15.2.2.3. 29-31 mm
  - 15.2.2.4. More than 31 mm
- 15.2.3. Tricuspid Valve
- 15.2.4. Pulmonary Valve
15.3. Market Value Forecast By Material, 2020-2034
- 15.3.1. Biological Valves
  - 15.3.1.1. TAVI
  - 15.3.1.2. Surgical
  - 15.3.1.3. Others
- 15.3.2. Mechanical Valves
15.4. Market Value Forecast By Age Group, 2020-2034
- 15.4.1. Pediatric Patients
- 15.4.2. Adults
- 15.4.3. Geriatric Patients
15.5. Market Value Forecast By End-user, 2020-2034
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Others
15.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Type of Heart Valve
- 15.7.2. By Material
- 15.7.3. By Age Group
- 15.7.4. By End-user
- 15.7.5. By Country / Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
- 16.2.1. Medtronic plc
  - 16.2.1.1. Company Overview
  - 16.2.1.2. Financial Overview
  - 16.2.1.3. Product Portfolio
  - 16.2.1.4. Business Strategies
  - 16.2.1.5. Recent Developments
- 16.2.2. Boston Scientific Corporation
  - 16.2.2.1. Company Overview
  - 16.2.2.2. Financial Overview
  - 16.2.2.3. Product Portfolio
  - 16.2.2.4. Business Strategies
  - 16.2.2.5. Recent Developments
- 16.2.3. Abbott
  - 16.2.3.1. Company Overview
  - 16.2.3.2. Financial Overview
  - 16.2.3.3. Product Portfolio
  - 16.2.3.4. Business Strategies
  - 16.2.3.5. Recent Developments
- 16.2.4. Edwards Lifesciences Corporation
  - 16.2.4.1. Company Overview
  - 16.2.4.2. Financial Overview
  - 16.2.4.3. Product Portfolio
  - 16.2.4.4. Business Strategies
  - 16.2.4.5. Recent Developments
- 16.2.5. Foldax Inc.
  - 16.2.5.1. Company Overview
  - 16.2.5.2. Financial Overview
  - 16.2.5.3. Product Portfolio
  - 16.2.5.4. Business Strategies
  - 16.2.5.5. Recent Developments
- 16.2.6. Novostia SA
  - 16.2.6.1. Company Overview
  - 16.2.6.2. Financial Overview
  - 16.2.6.3. Product Portfolio
  - 16.2.6.4. Business Strategies
  - 16.2.6.5. Recent Developments
- 16.2.7. Meril Life Sciences Pvt. Ltd.
  - 16.2.7.1. Company Overview
  - 16.2.7.2. Financial Overview
  - 16.2.7.3. Product Portfolio
  - 16.2.7.4. Business Strategies
  - 16.2.7.5. Recent Developments
- 16.2.8. Corcym UK Limited
  - 16.2.8.1. Company Overview
  - 16.2.8.2. Financial Overview
  - 16.2.8.3. Product Portfolio
  - 16.2.8.4. Business Strategies
  - 16.2.8.5. Recent Developments
- 16.2.9. JenaValve Technology, Inc.
  - 16.2.9.1. Company Overview
  - 16.2.9.2. Financial Overview
  - 16.2.9.3. Product Portfolio
  - 16.2.9.4. Business Strategies
  - 16.2.9.5. Recent Developments
- 16.2.10. Micro Interventional Devices, Inc.
  - 16.2.10.1. Company Overview
  - 16.2.10.2. Financial Overview
  - 16.2.10.3. Product Portfolio
  - 16.2.10.4. Business Strategies
  - 16.2.10.5. Recent Developments
- 16.2.11. Auto Tissue Berlin GmbH
  - 16.2.11.1. Company Overview
  - 16.2.11.2. Financial Overview
  - 16.2.11.3. Product Portfolio
  - 16.2.11.4. Business Strategies
  - 16.2.11.5. Recent Developments
- 16.2.12. Anteris Technologies Ltd
  - 16.2.12.1. Company Overview
  - 16.2.12.2. Financial Overview
  - 16.2.12.3. Product Portfolio
  - 16.2.12.4. Business Strategies
  - 16.2.12.5. Recent Developments
- 16.2.13. Thubrikar Aortic Valve, Inc.
  - 16.2.13.1. Company Overview
  - 16.2.13.2. Financial Overview
  - 16.2.13.3. Product Portfolio
  - 16.2.13.4. Business Strategies
  - 16.2.13.5. Recent Developments
- 16.2.14. MicroPort Scientific Corporation
  - 16.2.14.1. Company Overview
  - 16.2.14.2. Financial Overview
  - 16.2.14.3. Product Portfolio
  - 16.2.14.4. Business Strategies
  - 16.2.14.5. Recent Developments
- 16.2.15. Biosensors International Group, Ltd.
  - 16.2.15.1. Company Overview
  - 16.2.15.2. Financial Overview
  - 16.2.15.3. Product Portfolio
  - 16.2.15.4. Business Strategies
  - 16.2.15.5. Recent Developments